Astrana Health (NASDAQ:ASTH) Stock Rating Upgraded by Truist Financial

Astrana Health (NASDAQ:ASTH) was upgraded by research analysts at Truist Financial from a “hold” rating to a “buy” rating in a research note issued on Thursday, Marketbeat reports. The firm presently has a $50.00 price target on the stock, up from their previous price target of $44.00. Truist Financial’s price target points to a potential upside of 5.95% from the company’s current price.

A number of other research analysts have also weighed in on the stock. Baird R W raised shares of Astrana Health to a “strong-buy” rating in a research note on Thursday, May 30th. Stifel Nicolaus lifted their price objective on Astrana Health from $45.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, June 27th. Finally, Robert W. Baird initiated coverage on Astrana Health in a report on Thursday, May 30th. They issued an “outperform” rating and a $54.00 target price for the company. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $50.50.

Astrana Health Price Performance

Shares of NASDAQ:ASTH opened at $47.19 on Thursday. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.52 and a quick ratio of 1.52. Astrana Health has a 1 year low of $28.86 and a 1 year high of $48.34. The firm has a market capitalization of $2.64 billion, a price-to-earnings ratio of 35.75, a PEG ratio of 1.36 and a beta of 1.16. The stock has a 50 day moving average price of $40.20.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). The business had revenue of $404.36 million for the quarter, compared to analyst estimates of $413.84 million. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same period last year, the firm earned $0.42 EPS. As a group, analysts expect that Astrana Health will post 1.41 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.